NR3C2 and hypertensive disorder: While a small number of studies have explored the potential protective effects of spironolactone in the kidney [29–32], no studies to our knowledge have examined the actions of mineralocorticoid receptor antagonists on progressive cardiac injury and kidney injury after myocardial infarction in an animal model of established hypertension.